Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7P8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,637
Award facts
- Contract value 100% obligated
- $6,637.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,637.09 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 13, 2026, and performance to be executed from the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The company has demonstrated its capability to meet federal procurement requirements through open competition, with consistent delivery of pharmaceuticals across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV7P8?
SPE2DR26FV7P8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV7P8 worth?
The government has obligated $6,637 on SPE2DR26FV7P8.
Is contract SPE2DR26FV7P8 an order under another contract?
Yes. SPE2DR26FV7P8 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7P8 competed?
The extent of competition for SPE2DR26FV7P8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award